Tapsi Kumar News Today

MD Anderson researchers are driven by a shared goal to end cancer. Here are 22 of their most impactful accomplishments from this past year.

The finding contrasts with the previous thought that most later recurrences arise from the original ductal carcinoma in situ lesion.

A new study led by the global Cancer Grand Challenges PRECISION team, including researchers from The University of Texas MD Anderson Cancer Center, shifts the long-held belief that all invasive breast cancers following ductal carcinoma in situ (DCIS) arise from the original DCIS lesion.

Credit: MD Anderson Cancer Center HOUSTON — In an effort to address a major challenge when analyzing large single-cell RNA-sequencing datasets, researchers from The University of Texas MD Anderson Cancer Center have developed a new computational technique to accurately differentiate between data from cancer cells and the variety of normal cells found within tumor samples. The work was published today in Nature Biotechnology. The new tool, dubbed CopyKAT (copy number karyotyping of aneuploid ...